2016 European Guidelines on cardiovascular disease prevention in clinical practice
Top Cited Papers
Open Access
- 23 May 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 37 (29) , 2315-2381
- https://doi.org/10.1093/eurheartj/ehw106
Abstract
Cardiovascular disease (CVD) prevention is defined as a coordinated set ofactions, at the population level or targeted at an individual, that are aimed ateliminating or minimizing the impact of CVDs and their relateddisabilities.1CVD remains a leading cause of morbidity and mortality, despite improvements inoutcomes. Age-adjusted coronary artery disease (CAD) mortality has declinedsince the 1980s, particularly in high-income regions.2 CAD rates are now less than half what theywere in the early 1980s in many countries in Europe, due to preventive measuresincluding the success of smoking legislation. However, inequalities betweencountries persist and many risk factors, particularly obesity3 and diabetes mellitus(DM),4 have beenincreasing substantially. If prevention was practised as instructed it wouldmarkedly reduce the prevalence of CVD. It is thus not only prevailing riskfactors that are of concern, but poor implementation of preventive measures aswell.5,6 Prevention should bedelivered (i) at the general population level by promoting healthy lifestylebehaviour7 and(ii) at the individual level, i.e. in those subjects at moderate to high risk ofCVD or patients with established CVD, by tackling unhealthy lifestyles (e.g.poor-quality diet, physical inactivity, smoking) and by optimising risk factors.Prevention is effective: the elimination of health risk behaviours would make itpossible to prevent at least 80% of CVDs and even 40% of cancers.8,9Keywords
This publication has 543 references indexed in Scilit:
- Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromsø StudyEuropean Journal of Epidemiology, 2013
- General health checks in adults for reducing morbidity and mortality from diseaseCochrane Database of Systematic Reviews, 2012
- Informed Choice in Direct‐to‐Consumer Genetic Testing (DTCGT) Websites: A Content Analysis of Benefits, Risks, and LimitationsJournal of Genetic Counseling, 2011
- Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in NorwayEuropean Journal of Epidemiology, 2011
- Association of Socioeconomic Position With Health Behaviors and MortalityJAMA, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Periodontitis and incidence of cerebrovascular disease in menAnnals of Neurology, 2009
- Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and MortalityJAMA, 2008
- Left Ventricular Architecture and Survival in African-Americans Free of Coronary Heart Disease (from the Atherosclerosis Risk in Communities [ARIC] Study)The American Journal of Cardiology, 2007
- Depression and Medication Adherence in Outpatients With Coronary Heart DiseaseArchives of internal medicine (1960), 2005